Stocks · US
JNJ
XNYS
Johnson & Johnson
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E28.97x
P/B7.17x
P/S6.22x
EPS$8.73
ROE24.76%
ROA10.46%
Dividend yield2.07%
EV/EBITDA18.83x
Debt/Equity0.58
Free cash flow$22.2B
Returns and 52-week range
1W-4.78%
1M-7.43%
3M-3.27%
6M+6.87%
1Y+35.06%
YTD+22.87%
52W high$281.07
52W low$184.66
From 52W high-9.35%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 애브비 | $469.6B | 74.66 | — | +3.99% |
| 머크 | $344.3B | 108.50 | 8.21 | -5.58% |
| 유나이티드헬스 그룹 | $339.8B | 24.06 | 3.45 | -5.24% |
| 노바티스(ADR) | $267.9B | 39.64 | 3.70 | -12.00% |
| 써모 피셔 사이언티픽 | $250.2B | 35.92 | 4.75 | +6.97% |
| 아스트라제네카 | $242.8B | 109.30 | 17.94 | -2.51% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.